Endothelial differentiation in intracerebral and subcutaneous experimental gliomas

O. Arosarena, C. Guerin, Henry Brem, John J Laterra

Research output: Contribution to journalArticle

Abstract

Blood-brain barrier (BBB) properties of endothelial cells have on impact on brain tumor behavior, diagnosis, and response to therapy. Biochemical BBB properties are expressed by endothelial cells within intracerebral (IC) gliomas but little is known regarding the expression of BBB-associated proteins within gliomas established subcutaneously (SC), a site that is frequently used in experimental glioma models. We compared the expression of two BBB proteins, glucose transporter type-1 (Glut1) and endothelial barrier antigen (EBA), in IC and SC rat 9L and F98 gliomas. The percentage of microvessels with immunohistochemically-detectable Glut1 and EBA in IC 9L tumors (31-98%) contrasted with that found in SC 9L tumors (0-3.9%) (P <0.0001). Likewise, the percentage of immunohistochemically-positive vessels in IC F98 tumors (35-66%) differed markedly from that in SC F98 tumors (0%) (P <0.00001). These differences were not explained by effects of tumor location on vessel density or tumor histology. These findings demonstrate that the peritumoral environment influences endothelial differentiation within glial tumors and suggest that glioma cells maintain but do not induce the expression of barrier properties in vessels that infiltrate tumor from surrounding tissue.

Original languageEnglish (US)
Pages (from-to)98-104
Number of pages7
JournalBrain Research
Volume640
Issue number1-2
DOIs
StatePublished - Mar 21 1994

Fingerprint

Glioma
Blood-Brain Barrier
Neoplasms
Glucose Transporter Type 1
Endothelial Cells
Microvessels
Brain Neoplasms
Neuroglia
Histology
Proteins
Theoretical Models

Keywords

  • Blood-brain barrier
  • Differentiation
  • Endothelium
  • Glioma
  • Microvessel

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Endothelial differentiation in intracerebral and subcutaneous experimental gliomas. / Arosarena, O.; Guerin, C.; Brem, Henry; Laterra, John J.

In: Brain Research, Vol. 640, No. 1-2, 21.03.1994, p. 98-104.

Research output: Contribution to journalArticle

@article{17f2ec48ba6a4f8c878c9e9b329908a2,
title = "Endothelial differentiation in intracerebral and subcutaneous experimental gliomas",
abstract = "Blood-brain barrier (BBB) properties of endothelial cells have on impact on brain tumor behavior, diagnosis, and response to therapy. Biochemical BBB properties are expressed by endothelial cells within intracerebral (IC) gliomas but little is known regarding the expression of BBB-associated proteins within gliomas established subcutaneously (SC), a site that is frequently used in experimental glioma models. We compared the expression of two BBB proteins, glucose transporter type-1 (Glut1) and endothelial barrier antigen (EBA), in IC and SC rat 9L and F98 gliomas. The percentage of microvessels with immunohistochemically-detectable Glut1 and EBA in IC 9L tumors (31-98{\%}) contrasted with that found in SC 9L tumors (0-3.9{\%}) (P <0.0001). Likewise, the percentage of immunohistochemically-positive vessels in IC F98 tumors (35-66{\%}) differed markedly from that in SC F98 tumors (0{\%}) (P <0.00001). These differences were not explained by effects of tumor location on vessel density or tumor histology. These findings demonstrate that the peritumoral environment influences endothelial differentiation within glial tumors and suggest that glioma cells maintain but do not induce the expression of barrier properties in vessels that infiltrate tumor from surrounding tissue.",
keywords = "Blood-brain barrier, Differentiation, Endothelium, Glioma, Microvessel",
author = "O. Arosarena and C. Guerin and Henry Brem and Laterra, {John J}",
year = "1994",
month = "3",
day = "21",
doi = "10.1016/0006-8993(94)91861-9",
language = "English (US)",
volume = "640",
pages = "98--104",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Endothelial differentiation in intracerebral and subcutaneous experimental gliomas

AU - Arosarena, O.

AU - Guerin, C.

AU - Brem, Henry

AU - Laterra, John J

PY - 1994/3/21

Y1 - 1994/3/21

N2 - Blood-brain barrier (BBB) properties of endothelial cells have on impact on brain tumor behavior, diagnosis, and response to therapy. Biochemical BBB properties are expressed by endothelial cells within intracerebral (IC) gliomas but little is known regarding the expression of BBB-associated proteins within gliomas established subcutaneously (SC), a site that is frequently used in experimental glioma models. We compared the expression of two BBB proteins, glucose transporter type-1 (Glut1) and endothelial barrier antigen (EBA), in IC and SC rat 9L and F98 gliomas. The percentage of microvessels with immunohistochemically-detectable Glut1 and EBA in IC 9L tumors (31-98%) contrasted with that found in SC 9L tumors (0-3.9%) (P <0.0001). Likewise, the percentage of immunohistochemically-positive vessels in IC F98 tumors (35-66%) differed markedly from that in SC F98 tumors (0%) (P <0.00001). These differences were not explained by effects of tumor location on vessel density or tumor histology. These findings demonstrate that the peritumoral environment influences endothelial differentiation within glial tumors and suggest that glioma cells maintain but do not induce the expression of barrier properties in vessels that infiltrate tumor from surrounding tissue.

AB - Blood-brain barrier (BBB) properties of endothelial cells have on impact on brain tumor behavior, diagnosis, and response to therapy. Biochemical BBB properties are expressed by endothelial cells within intracerebral (IC) gliomas but little is known regarding the expression of BBB-associated proteins within gliomas established subcutaneously (SC), a site that is frequently used in experimental glioma models. We compared the expression of two BBB proteins, glucose transporter type-1 (Glut1) and endothelial barrier antigen (EBA), in IC and SC rat 9L and F98 gliomas. The percentage of microvessels with immunohistochemically-detectable Glut1 and EBA in IC 9L tumors (31-98%) contrasted with that found in SC 9L tumors (0-3.9%) (P <0.0001). Likewise, the percentage of immunohistochemically-positive vessels in IC F98 tumors (35-66%) differed markedly from that in SC F98 tumors (0%) (P <0.00001). These differences were not explained by effects of tumor location on vessel density or tumor histology. These findings demonstrate that the peritumoral environment influences endothelial differentiation within glial tumors and suggest that glioma cells maintain but do not induce the expression of barrier properties in vessels that infiltrate tumor from surrounding tissue.

KW - Blood-brain barrier

KW - Differentiation

KW - Endothelium

KW - Glioma

KW - Microvessel

UR - http://www.scopus.com/inward/record.url?scp=0028347878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028347878&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(94)91861-9

DO - 10.1016/0006-8993(94)91861-9

M3 - Article

C2 - 8004469

AN - SCOPUS:0028347878

VL - 640

SP - 98

EP - 104

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -